Steakholder Foods (NASDAQ:STKH), trading on NASDAQ under the symbol STKH, is a developer of cultivated meat and fat products based on cellular agriculture and 3D bioprinting technologies. The company focuses on producing structured, whole-cut meat and fat components by cultivating animal cells in controlled bioreactors, offering an alternative to conventionally farmed meat with the goal of reducing environmental impact and improving food safety.
Originally founded as MeaTech 3D in Israel, the company rebranded to Steakholder Foods in early 2022 and completed its public listing on NASDAQ through a merger with a special purpose acquisition company. Since then, Steakholder Foods has expanded its research and development activities, establishing pilot facilities and collaboration centers in Israel and Europe. These sites support the refinement of bioprinting methods and scalability studies for both meat and fat products, with a particular emphasis on beef fat derivatives.
Steakholder Foods’ product development pipeline includes cell-derived fats designed to enhance the taste, texture, and mouthfeel of alternative protein products. By integrating cultivated fats into plant-based and hybrid meat formulations, the company aims to bridge the gap between traditional meat experiences and emerging protein categories. Its research partnerships span academic institutions and industry players, targeting cost efficiencies, regulatory compliance, and production scale-up.
Serving global markets, Steakholder Foods is positioning itself to supply ingredient and co-manufacturing solutions to food companies seeking to incorporate cultivated components into their portfolios. Led by a management team with expertise in biotechnology, food science, and commercial manufacturing, the firm continues to advance toward regulatory approvals and commercial launches of its cultured meat and fat offerings.
